| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials
|
Milbradt, Tanize Louize
|
|
|
29 |
5 |
p. 1039-1047
|
artikel
|
| 2 |
Anti-obesity medications in the management of heart failure with preserved ejection fraction: available evidence and next STEPS
|
Harrington, Josephine
|
|
|
29 |
5 |
p. 939-944
|
artikel
|
| 3 |
Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium
|
Shoji, Satoshi
|
|
|
29 |
5 |
p. 949-955
|
artikel
|
| 4 |
Biosensors with left ventricular assist devices
|
Abbassy, Mahmoud
|
|
|
29 |
5 |
p. 957-967
|
artikel
|
| 5 |
Evaluating the role of interatrial shunt devices in heart failure management: insights from the RELIEVE-HF trial
|
Sideris, Konstantinos
|
|
|
29 |
5 |
p. 909-912
|
artikel
|
| 6 |
Extended thromboprophylaxis in heart failure patients; the unmet need
|
Al Yami, Majed S.
|
|
|
29 |
5 |
p. 1107-1116
|
artikel
|
| 7 |
Ex vivo heart perfusion: an updated systematic review
|
Pradegan, Nicola
|
|
|
29 |
5 |
p. 1079-1096
|
artikel
|
| 8 |
High-intensity care for GDMT titration
|
Biegus, Jan
|
|
|
29 |
5 |
p. 1065-1077
|
artikel
|
| 9 |
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis
|
Hiraiwa, Hiroaki
|
|
|
29 |
5 |
p. 1049-1063
|
artikel
|
| 10 |
Management of patients with heart failure and chronic kidney disease
|
Wu, Lingling
|
|
|
29 |
5 |
p. 989-1023
|
artikel
|
| 11 |
Navigating the penetrance and phenotypic spectrum of inherited cardiomyopathies
|
Serpa, Frans
|
|
|
29 |
5 |
p. 873-881
|
artikel
|
| 12 |
New insights gained from cellular landscape changes in myocarditis and inflammatory cardiomyopathy
|
Wang, Weiteng
|
|
|
29 |
5 |
p. 883-907
|
artikel
|
| 13 |
Nexilin in cardiomyopathy: unveiling its diverse roles with special focus on endocardial fibroelastosis
|
Rahimzadeh, Mahsa
|
|
|
29 |
5 |
p. 1025-1037
|
artikel
|
| 14 |
Non-invasive heart failure monitoring: leveraging smart scales and digital biomarkers to improve heart failure outcomes
|
Wattanachayakul, Phuuwadith
|
|
|
29 |
5 |
p. 1145-1156
|
artikel
|
| 15 |
Renal function in PUSH-AHF: a summary of newly released data from the 2024 Annual Congress of the Heart Failure Association of the ESC
|
Yacob, Alexander Aaron
|
|
|
29 |
5 |
p. 945-948
|
artikel
|
| 16 |
Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
|
Khan, Laibah Arshad
|
|
|
29 |
5 |
p. 1157-1160
|
artikel
|
| 17 |
STEP HFpEF DM: a sweet sequel
|
Harrington, Josephine
|
|
|
29 |
5 |
p. 913-915
|
artikel
|
| 18 |
Stress echocardiography in heart failure patients: additive value and caveats
|
Pastore, Maria Concetta
|
|
|
29 |
5 |
p. 1117-1133
|
artikel
|
| 19 |
The role of NETosis in heart failure
|
Kostin, Sawa
|
|
|
29 |
5 |
p. 1097-1106
|
artikel
|
| 20 |
The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol
|
Dutka, Mieczysław
|
|
|
29 |
5 |
p. 917-937
|
artikel
|
| 21 |
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
|
Matusik, Katarzyna
|
|
|
29 |
5 |
p. 969-988
|
artikel
|
| 22 |
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?
|
Correale, Michele
|
|
|
29 |
5 |
p. 1135-1143
|
artikel
|
Tijdschrift beschrijving